This biotech firm has room to run despite surging nearly 500% in past year, Morgan Stanley says
- Posted on April 21, 2026
- By CNBC
- 0 Views
- 1 min read
This biotech firm has room to run despite surging nearly 500% in past year, Morgan Stanley says
The investment bank upgraded the pharma stock to overweight from equal weight.
